Evidence map›Paper›PMID 36674624›Full record

ArticleInternational journal of molecular sciences2023

PLVAP as an Early Marker of Glomerular Endothelial Damage in Mice with Diabetic Kidney Disease.

Elena E Wolf, Anne Steglich, Friederike Kessel, Hannah Kröger, Jan Sradnick, Simone Reichelt-Wurm, Kathrin Eidenschink, Miriam C Banas, Eckhard Wolf, Rüdiger Wanke and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Elena E WolfExperimental Nephrology, Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.ORCID 0000-0001-9446-5439
Anne SteglichExperimental Nephrology, Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Friederike KesselExperimental Nephrology, Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Hannah KrögerExperimental Nephrology, Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.ORCID 0000-0002-8059-4368
Jan SradnickExperimental Nephrology, Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Simone Reichelt-WurmDepartment of Nephrology, University Hospital Regensburg, 93053 Regensburg, Germany.
Kathrin EidenschinkDepartment of Nephrology, University Hospital Regensburg, 93053 Regensburg, Germany.
Miriam C BanasDepartment of Nephrology, University Hospital Regensburg, 93053 Regensburg, Germany.
Eckhard WolfMolecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.ORCID 0000-0002-0430-9510
Rüdiger WankeInstitute of Veterinary Pathology, Center for Clinical Veterinary Medicine, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
Florian GembardtExperimental Nephrology, Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.ORCID 0000-0003-2739-345X
Vladimir T TodorovExperimental Nephrology, Division of Nephrology, Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.ORCID 0000-0002-7011-8130
University Hospital Carl Gustav Carus · DEUniversity Hospital Regensburg · DEDeutsches Diabetes-Zentrum e.V. · DELudwig-Maximilians-Universität München · DE

Funding

Deutsche Forschungsgemeinschaft 399229660Deutsche Forschungsgemeinschaft 426572058Deutsche Forschungsgemeinschaft 470138795
6 · The paper itself

Abstract

Plasmalemma vesicle-associated protein (PLVAP) is the main component of endothelial diaphragms in fenestrae, caveolae, and transendothelial channels. PLVAP is expressed in the adult kidney glomerulus upon injury. Glomerular endothelial injury is associated with progressive loss of kidney function in diabetic kidney disease (DKD). This study aimed to investigate whether PLVAP could serve as a marker for glomerular endothelial damage in DKD. Glomerular PLVAP expression was analyzed in different mouse models of DKD and their respective healthy control animals using automatic digital quantification of histological whole kidney sections. Transgenic mice expressing a dominant-negative GIP receptor (GIPR

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic NephropathiesAnimalsKidneyKidney GlomerulusMembrane ProteinsMiceMice, Inbred StrainsMice, TransgenicMembrane ProteinsPlvap protein, mousediabetic kidney diseasediabetic modelsendothelial damageglomerular hypertrophyPLVAP

Identifiers

PMID36674624
PMCPMC9865597
OpenAlexW4313646647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.